drugset / Trial / NCT02252809
Effect of Anti-Inflammatory Agents on Biological Responses to Endotoxin Inhalation in Healthy Subjects
RandomizedParallel-groupOpen-labelBasic science
Summary
The main objective of this study is to characterize the biological responses elicited by endotoxin inhalation applied to healthy subjects, and to assess the effect of standard anti-inflammatory agents (i.e. adalimumab and methylprednisolone) on these biological responses.
Timeline
- Start
- 2008-11
- Primary completion
- 2009-04
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Adalimumab | Monoclonal antibody | 40 mg | Subcutaneous |
| Comparator | Methylprednisolone | Other / unclassified | 20 mg | Oral |
Indications
No indication recorded.